C226 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I
| Event Time: | Thursday May 9, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Autoimmune Neurology, MS and CNS Inflammatory Disease |
| Director(s): | Jeffrey Gelfand MD, MAS, FAAN |
| Description: | An interdisciplinary faculty of neurologists and rheumatologists will provide an update on neuro-rheumatology - the neurologic manifestations of systemic inflammatory and autoimmune syndromes. Part I of this course will cover updates in rheumatological diagnosis, physical examination techniques, and interpretation of laboratory studies; discuss neurologic manifestations and treatment of Systemic Lupus Erythematosus, Sjogren's Syndrome, Mixed Connective Tissue Disease, Rheumatoid Arthritis, and Antiphospholipid Antibody Syndrome; and review CNS Vasculitis and other vasculitides and their mimics. Part II will cover updates in diagnosis and treatment of Neurosarcoidosis, Pachymeningitis and Behcet's Disease; discuss Peripheral Nervous System Manifestations of Rheumatological Diseases; and conclude with an interdisciplinary case discussion with faculty highlighting how rheumatologists and neurologists approach differential diagnosis, treatment, and management. This program complements Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II, but covers independent topics. |
| Completion Message: | Participants should become familiar with the differential diagnosis of neurological manifestations of rheumatological, systemic inflammatory and other autoimmune diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neuro-rheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement, Systems-Based Practice |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:05 PM | Introduction and Course Overview | Jeffrey Marc Gelfand MD, MAS, FAAN |
| 1:05 PM - 1:40 PM | Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Laboratory Studies: Lessons for the Practicing Neurologist | Jennifer Mandal MD |
| 1:40 PM - 2:20 PM | Systemic Lupus Erythematosus, Sjogren's Disease, Antiphospholipid Antibody Syndrome, Rheumatoid Arthritis, and Mixed Connective Tissue Disease: Neurological Manifestations | Shamik Bhattacharyya MD |
| 2:20 PM - 3:00 PM | Peripheral Nervous System Manifestations of Rheumatological Disease | Kelly G. Gwathmey MD |
| Speaker | Disclosure |
|---|---|
| Shamik Bhattacharyya, MD | Dr. Bhattacharyya has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Advance Medical. |
| Jeffrey Marc Gelfand, MD, MAS, FAAN | Dr. Gelfand has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen and Alexion. His spouse has received personal compensation for consulting for Theranica, Impel Neuropharma, Eli Lilly, Impax and Zosano and to UCSF from eNeura. Dr. Gelfand personal fees as an expert for medical legal consulting from Alkem Laboratories Ltd., Accord Healthcare Inc, Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc., Roxane Laboratories, Inc., Mylan Pharmaecuticals Inc., Merck, and from the United States Department of Health and Human Services and United States Department of Justice (Vaccine Injury Compensation Program). His spouse has also received personal fees for medical legal consulting. Dr. Gelfand has received personal compensation in an editorial capacity for content review for Dynamed Plus. He serves on the editorial advisory board for Neurology Neuroimmunology and Neuroinflammation. Dr. Gelfand's spouse received honoraria from JAMA Neurology as an Associate Editor and honoraria for writing from UptoDate . Dr. Gelfand has received research support from Genentech (to UCSF) for a clinical trial; he received service contract support from MedDay (to UCSF) for a clinical trial. His spouse received research support from Amgen (to UCSF). |
| Kelly G. Gwathmey, MD | Dr. Gwathmey has nothing to disclose. |
| Jennifer Mandal, MD | Dr. Mandal has nothing to disclose. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C7 -
Clinical Pearls in Autoimmune Neurology: Real World Cases
Stacey Clardy MD, PhD |
| 9:30 AM-11:30 AM |
|
C19 -
Multiple Sclerosis Overview I: Clinical Pearls
Mary Willis MD |
| 1:30 PM-3:30 PM |
|
C29 -
Multiple Sclerosis Overview II: Clinical Advances
Scott Newsome DO, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C44 -
Multiple Sclerosis Therapy: Symptom Management
Andrew Solomon MD, FAAN |
| 9:15 AM-12:00 PM |
|
Presidential Plenary Session
Natalia Rost MD, MPH, FAAN, FAHA |
| 11:30 AM-6:30 PM |
|
P1 -
Poster Session 1
|
| 1:00 PM-3:00 PM |
|
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
|
C56 -
Multiple Sclerosis Therapy: Disease-modifying Treatment I
Scott Newsome DO, FAAN |
|
S6 -
MS and CNS Inflammatory Disease: Clinical Considerations I
|
| 3:30 PM-5:30 PM |
|
C73 -
Multiple Sclerosis Therapy: Disease-modifying Treatment II
John Rose MD, FAAN |
|
S11 -
Autoimmune CNS Inflammatory Disorders: Clinical Advances
|
| 7:00 AM-9:00 AM |
|---|
|
C79 -
Differential Diagnosis of Neurologic Infections
Michael Wilson MD, FAAN |
|
C86 -
Neuromyelitis Optica Spectrum Disorders
Dean Wingerchuk MD, FAAN |
| 9:15 AM-12:00 PM |
|
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
| 11:30 AM-6:30 PM |
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
C100 -
Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders)
Lilyana Amezcua MD, FAAN |
|
S12 -
Progressive Multiple Sclerosis
|
| 3:30 PM-5:30 PM |
|
C109 -
Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
|
S19 -
Child Neurology: Updates in Autism, Migraine, MS, and Stroke
|
|
S21 -
Autoimmune Neurology: Novel Diagnostic and Predictive Biomarkers and Immunopathologic Mechanisms of Disease
|
| 7:00 AM-9:00 AM |
|---|
|
C130 -
Diagnostic Pearls in Myelitis: a Case-based Approach
Eoin Flanagan MBBCh |
| 9:15 AM-11:30 AM |
|
Clinical Trials Plenary Session
Holly Hinson MD, MCR, FAAN, Deborah Hall MD, PhD, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 1:00 PM-3:00 PM |
|
C142 -
Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS
Stacey Clardy MD, PhD |
|
N3 -
Neuroscience in the Clinic: Stem Cells
Paul George MD, PhD, MSE, Antonio Omuro MD |
|
S26 -
MS and CNS Inflammatory Disease: Clinical Considerations II
|
| 3:30 PM-5:30 PM |
|
C160 -
Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience
Eoin Flanagan MBBCh |
|
S31 -
MS and CNS Inflammatory Disease: Imaging
|
| 7:00 AM-9:00 AM |
|---|
|
C171 -
Child Neurology: Neuromuscular/Autoimmune Neurology
Anne Connolly MD, FAAN |
| 9:15 AM-11:30 AM |
|
Frontiers in Neuroscience Plenary Session
Paul George MD, PhD, MSE |
| 11:30 AM-6:30 PM |
|
P4 -
Poster Session 4
|
| 1:00 PM-3:00 PM |
|
C181 -
Treatment of Pediatric Multiple Sclerosis in the Current Era
Brenda Banwell MD, FAAN |
|
N4 -
Neuroscience in the Clinic: Immunotherapies in Neurological Disease
John Corboy MD, FAAN, Holly Hinson MD, MCR, FAAN |
|
S37 -
MS Biomarkers
|
| 2:00 PM-2:30 PM |
|
TALK CANCELLED: A Career in Autoimmune Neurology
Pooja Raibagkar MD |
| 3:30 PM-5:30 PM |
|
S43 -
Immunotherapies and Drug Trials in Autoimmune Neurological Disorders
|
|
Presentation of the John Dystel Prize for Multiple Sclerosis Research
|
| 3:45 PM-4:15 PM |
|
Update on the Complementary Therapies for MS: An Evidence-based Review
Vijayshree Yadav MD, FAAN |
| 11:30 AM-6:30 PM |
|---|
|
P5 -
Poster Session 5
|
| 12:00 PM-12:45 PM |
|
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time
Mary Rensel MD, FAAN, Nancy Isenberg MD, MPH, FAAN |
| 1:00 PM-3:00 PM |
|
S49 -
MS Epidemiology and Risk Stratification
|
| 3:30 PM-5:30 PM |
|
C236 -
Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II
Jeffrey Gelfand MD, MAS, FAAN |
|
N6 -
Neuroscience in the Clinic: The Brain Across the Menstrual Cycle
Temitayo Oyegbile MD, PhD, Riley Bove MD |
|
S55 -
MS Basic Science
|
| 7:00 AM-9:00 AM |
|---|
|
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
S56 -
MS Trials and Treatment
|
| 3:30 PM-4:30 PM |
|
C257 -
Education Blitz: Evolution of Autoimmune Neurology
Steven Vernino MD, PhD, FAAN |
|
C258 -
Education Blitz: Multiple Sclerosis
Stephen Krieger MD, FAAN |